Page last updated: 2024-11-12

transportan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

transportan: a galparan (C107160) analog, useful as a carrier vector for hydrophilic molecule, therefore named transportan; amino acid sequence known [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16134049
MeSH IDM0285485

Synonyms (2)

Synonym
transportan
nh2-gly-trp-thr-leu-asn-ser-ala-gly-tyr-leu-leu-gly-lys-ile-asn-leu-lys-ala-leu-ala-ala-leu-ala-lys-lys-ile-leu-nh2

Research Excerpts

Overview

Transportan 10 (TP10) is an amphipathic cell-penetrating peptide with high translocation ability. It is a 27 amino acid-long peptide containing 12 functional amino acids from the amino terminus of the neuropeptide galanin and mastoparan.

ExcerptReferenceRelevance
"Transportan 10 (TP10) is an amphipathic cell-penetrating peptide with high translocation ability. "( Cellular uptake of transportan 10 and its analogs in live cells: Selectivity and structure-activity relationship studies.
Kai, M; Liu, L; Liu, X; Song, J; Wang, R; Zhang, B; Zhang, J; Zhang, W, 2011
)
2.14
"Transportan is a chimeric cell-penetrating peptide constructed from the peptides galanin and mastoparan, which has the ability to internalize living cells carrying a hydrophilic load. "( NMR solution structure and position of transportan in neutral phospholipid bicelles.
Andersson, A; Bárány-Wallje, E; Gräslund, A; Mäler, L, 2004
)
2.04
"Transportan is a 27 amino acid-long peptide containing 12 functional amino acids from the amino terminus of the neuropeptide galanin and mastoparan in the carboxyl terminus, connected via a lysine. "( Cell penetration by transportan.
Hällbrink, M; Langel, U; Pooga, M; Zorko, M, 1998
)
2.07
"Transportan is a 27-residue peptide (GWTLN SAGYL LGKIN LKALA ALAKK IL-amide) which has the ability to penetrate into living cells carrying a hydrophilic load. "( Secondary structure and position of the cell-penetrating peptide transportan in SDS micelles as determined by NMR.
Gräslund, A; Jarvet, J; Langel, U; Lindberg, M, 2001
)
1.99
"Transportan is a synthetic chimera (galanin and mastoparan)."( Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles.
Eriksson, LE; Gräslund, A; Kilk, K; Langel, U; Magzoub, M, 2001
)
1.03

Toxicity

ExcerptReferenceRelevance
" Although the field has emerged as a possible future candidate for drug delivery, little attention has been given to the potential toxic side effects that these peptides might exhibit in cargo delivery."( Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
El-Andaloussi, S; Järver, P; Johansson, HJ; Langel, U, 2007
)
0.34
" PFs have shown high efficiency in nucleic acid delivery in vitro and in vivo; hence, the estimation of their possible toxic side effects would be of particular interest."( Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Arukuusk, P; Copolovici, DM; Eriste, E; Kurrikoff, K; Langel, U; Oskolkov, N; Suhorutsenko, J, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (7.84)18.2507
2000's29 (56.86)29.6817
2010's15 (29.41)24.3611
2020's3 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 107.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index107.15 (24.57)
Research Supply Index4.04 (2.92)
Research Growth Index5.07 (4.65)
Search Engine Demand Index190.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (107.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (5.36%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other53 (94.64%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]